Validation of a method for the determination of the anticancer agent Combretastatin A1 phosphate (CA1P, OXi4503) in human plasma by HPLC with post-column photolysis and fluorescence detection.

A validated method for the determination of Combretastatin A1 phosphate (CA1P, OXi4503), a bisphosphate prodrug of the vascular disrupting agent Combretastatin A1 in human plasma has been developed using fluorescence detection after post-column photolysis. The separation used the ion-pairing agent t...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính: Stratford, MR, Folkes, L
Định dạng: Journal article
Ngôn ngữ:English
Được phát hành: 2011